K. Akinwande et al., STRATEGIC-PLANNING FOR THE MANAGEMENT OF BIOTECHNOLOGIC PRODUCTS - DEVELOPMENT OF A BIOTECH COMMITTEE, Hospital formulary, 28(9), 1993, pp. 773
Strategies and tactics for managing biotechnologic products are critic
al to cope with the increasing number and cost of such products. one s
trategy is to develop a biotech committee to formulate long-term goals
for managing biotechnologic products and to evaluate controversial or
extremely expensive new products and recommend their formulary status
to the P & T Committee. Involvement of the P & T Committee is crucial
to establish strict criteria and monitors to ensure the appropriate a
nd cost-effective use of these products. Involvement of the pharmacy d
epartment is also essential to detect usage patterns and reimbursement
profiles of approved biotechnologic products in the hospital, as well
as their potential financial impact on the hospital's budget.